Clinical Trial Update: The Use of N-acetylcysteine for Thrombotic Events After Allogenic Hematopoietic Stem Cell Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating N-acetylcysteine for thrombotic events after allogeneic hematopoietic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombotic Disorder

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Thrombotic Disorder | Phase 3 | Status: UNKNOWN